| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CAD.0B013E328360B9D6 |
| P698 | PubMed publication ID | 23542750 |
| P2093 | author name string | Sylvie Chabaud | |
| Benjamin Lallemant | |||
| Jérôme Fayette | |||
| Philippe Céruse | |||
| Véronique Favrel | |||
| Marc Poupart | |||
| Céline Ferlay | |||
| Pascal Pommier | |||
| Antoine Ramade | |||
| Nathalie Bonnin | |||
| Philippe Zrounba | |||
| P2860 | cites work | Cancer statistics, 2009 | Q29547625 |
| P433 | issue | 6 | |
| P921 | main subject | head and neck carcinoma | Q18554836 |
| neck cancer | Q18966654 | ||
| advanced head and neck cancer | Q108565205 | ||
| cisplatin | Q412415 | ||
| cetuximab | Q420296 | ||
| P304 | page(s) | 623-629 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Anti-Cancer Drugs | Q4774128 |
| P1476 | title | Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients | |
| P478 | volume | 24 |
| Q92527773 | Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
| Q34742875 | Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck |
| Q37392967 | Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients |
| Q96133061 | Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China |
| Q36114633 | Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis |
| Q43104064 | Trial Watch: Radioimmunotherapy for oncological indications |
Search more.